1: Hung K, Lee BC, Chen PT, Liu KL, Chang CC, Wu VC, Lin YH. Influence of
autonomous cortisol secretion in patients with primary aldosteronism: subtype
analysis and postoperative outcome. Endocr Connect. 2023 Nov 8;12(12):e230121.
doi: 10.1530/EC-23-0121. PMID: 37800679.
2: Chen JY, Pan HC, Shiao CC, Chuang MH, See CY, Yeh TH, Yang Y, Chu WK, Wu VC.
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis.
Cardiovasc Diabetol. 2023 Oct 27;22(1):290. doi: 10.1186/s12933-023-02035-8.
PMID: 37891550; PMCID: PMC10612254.
3: Rossi GP, Bagordo D, Amar L, Azizi M, Riester A, Reincke M, Degenhart C,
Widimský J, Naruse M, Deinum J, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A,
Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill
SB, Shafigullina Z, Quinkler M, Oliveras A, Lee BC, Chang CC, Wu VC, Krátká Z,
Battistel M, Rossitto G, Seccia TM. Unilaterally Selective Adrenal Vein Sampling
for Identification of Surgically Curable Primary Aldosteronism. Hypertension.
2023 Oct;80(10):2003-2013. doi: 10.1161/HYPERTENSIONAHA.123.21247. Epub 2023 Jun
15. PMID: 37317838.
4: Wu VC, Chen JY, Lin YH, Wang CY, Lai CC. Assessing the cardiovascular events
and clinical outcomes of COVID-19 on patients with primary aldosteronism. J
Microbiol Immunol Infect. 2023 Sep 27:S1684-1182(23)00171-8. doi:
10.1016/j.jmii.2023.09.005. Epub ahead of print. PMID: 37827953.
5: Lai CF, Lin YH, Huang KH, Chueh JS, Wu VC; TAIPAI study group. Kidney
function predicts new-onset cardiorenal events and mortality in primary
aldosteronism: approach of the 2021 race-free eGFR equation. Hypertens Res. 2023
Sep 16. doi: 10.1038/s41440-023-01400-0. Epub ahead of print. PMID: 37714953.
6: Sheu JY, Wang SM, Wu VC, Huang KH, Tseng CS, Lee YJ, Tsai YC, Lin YH, Chueh
JS. Estimated glomerular filtration rate-dip after medical target therapy
associated with increased mortality and cardiovascular events in patients with
primary aldosteronism. J Hypertens. 2023 Sep 1;41(9):1401-1410. doi:
10.1097/HJH.0000000000003479. Epub 2023 Jun 8. PMID: 37334546.
7: Huang WC, Liu FH, Cheng HM, Tsai YC, Huang YT, Lai TS, Lin YH, Wu VC, Kao HL,
Jia-Yin Hou C, Wu KD, Chen ST, Er LK. Who needs to be screened for primary
aldosteronism? J Formos Med Assoc. 2023 Aug 24:S0929-6646(23)00335-2. doi:
10.1016/j.jfma.2023.08.021. Epub ahead of print. PMID: 37633770.
8: Kang VJ, Lee BC, Huang JZ, Wu VC, Lin YH, Chang CC; TAIPAI group.
Aldosterone-producing adenoma is associated with urolithiasis in primary
aldosteronism. Endocr Connect. 2023 Aug 11;12(9):e230056. doi:
10.1530/EC-23-0056. PMID: 37410081; PMCID: PMC10448598.
9: Chen LC, Huang WC, Peng KY, Chen YY, Li SC, Syed Mohammed Nazri SK, Lin YH,
Lin LY, Lu TM, Kim JH, Azizan EA, Hu J, Li Q, Chueh JS, Wu VC; TAIPAI Study
Groupi. Identifying <i>KCNJ</i>5 Mutation in Aldosterone-Producing Adenoma
Patients With Baseline Characteristics Using Machine Learning Technology. JACC
Asia. 2023 Jun 13;3(4):664-675. doi: 10.1016/j.jacasi.2023.03.010. PMID:
37614534; PMCID: PMC10442871.
10: Wu CY, Wu MJ, Chen CH, Yu TM, Chuang YW, Lin YH, Wu JT, Shiao CC, Wu VC.
Association of urinary liver-type fatty acid-binding protein with outcomes after
adrenalectomy for unilateral primary aldosteronism. Clin Chim Acta. 2023 Aug
1;548:117465. doi: 10.1016/j.cca.2023.117465. Epub 2023 Jun 30. PMID: 37394162.
11: Chang YL, Chen GY, Lee BC, Chen PT, Liu KL, Chang CC, Weng TI, Wu VC, Lin
YH; TAIPAI Study Group. Optimizing adrenal vein sampling in primary
aldosteronism subtyping through LC-MS/MS and secretion ratios of aldosterone,
18-oxocortisol, and 18-hydroxycortisol. Hypertens Res. 2023 Aug;46(8):1983-1994.
doi: 10.1038/s41440-023-01347-2. Epub 2023 Jun 13. PMID: 37311968; PMCID:
PMC10404510.
12: Chen ZW, Wu VC, Huang YT, Lin YH. From science to practice: Development of
evidence-based guidelines for primary aldosteronism. J Formos Med Assoc. 2023
Jun 27:S0929-6646(23)00241-3. doi: 10.1016/j.jfma.2023.06.013. Epub ahead of
print. PMID: 37385932.
13: Tseng CS, Chan CK, Lee HY, Pan CT, Peng KY, Wang SM, Huang KH, Tsai YC, Wu
VC, Chueh JS; TAIPAI Study Group. Treatment of primary aldosteronism: Clinical
practice guidelines of the Taiwan Society of Aldosteronism. J Formos Med Assoc.
2023 Jun 14:S0929-6646(23)00201-2. doi: 10.1016/j.jfma.2023.05.032. Epub ahead
of print. PMID: 37328332.
14: Lu JY, Chang YY, Lee TW, Wu MH, Chen ZW, Huang YT, Lai TS, Er LK, Lin YH, Wu
VC, Cheng HM, Kao HL, Jia-Yin Hou C, Wu KD, Chen ST, Liu FH. How should anti-
hypertensive medications be adjusted before screening for primary aldosteronism?
J Formos Med Assoc. 2023 Jun 6:S0929-6646(23)00190-0. doi:
10.1016/j.jfma.2023.05.021. Epub ahead of print. PMID: 37291044.
15: Huang WC, Chen YY, Yang SY, Lai CF, Lai TS, Chen HY, Chen L, Wang YJ, Cheng
YL, Lang CL, Chen CF, Chang HF, Peng JK, Lin LY, Cheng HM, Hwu CM, Lu TM, Chueh
JS, Lin YH, Wu VC. Fat mass as an important predictor of persistent hypertension
in patients with primary aldosteronism after adrenalectomy. Hypertens Res. 2023
Jun;46(6):1375-1384. doi: 10.1038/s41440-023-01203-3. Epub 2023 Feb 9. PMID:
36759661.
16: Yang YH, Chang YL, Lee BC, Lu CC, Wang WT, Hu YH, Liu HW, Lin YH, Chang CC,
Wu WC, Tseng FY, Lin YH, Wu VC, Hwu CM. Strategies for subtyping primary
aldosteronism. J Formos Med Assoc. 2023 May 16:S0929-6646(23)00155-9. doi:
10.1016/j.jfma.2023.05.004. Epub ahead of print. PMID: 37202237.
17: Huang CW, Tu KH, Fan KC, Tsai CH, Wang WT, Wang SY, Wu CY, Hu YH, Huang SH,
Liu HW, Tseng FY, Wu WC, Chang CC, Lin YH, Wu VC, Hwu CM. The role of
confirmatory tests in the diagnosis of primary aldosteronism. J Formos Med
Assoc. 2023 May 10:S0929-6646(23)00148-1. doi: 10.1016/j.jfma.2023.04.022. Epub
ahead of print. PMID: 37173227.
18: Lin CH, Lin CH, Chung MC, Hung CS, Tseng FY, Er LK, Jia-Yin Hou C, Lin YH,
Wu VC, Cheng HM, Kao HL, Wu KD, Lai TS. Aldosterone-to-renin ratio (ARR) as a
screening tool for primary aldosteronism (PA). J Formos Med Assoc. 2023 May
10:S0929-6646(23)00145-6. doi: 10.1016/j.jfma.2023.04.019. Epub ahead of print.
PMID: 37173226.
19: Lu YC, Liu KL, Wu VC, Wang SM, Lin YH, Chueh SJ, Wu KD, Su YR, Huang KH;
TAIPAI Study Group. Unilateral adrenalectomy in bilateral adrenal hyperplasia
with primary aldosteronism. J Formos Med Assoc. 2023 May;122(5):393-399. doi:
10.1016/j.jfma.2022.12.015. Epub 2023 Feb 20. PMID: 36813699.
20: Chang YY, Lee BC, Chen ZW, Tsai CH, Chang CC, Liao CW, Pan CT, Peng KY, Chou
CH, Lu CC, Wu VC, Hung CS, Lin YH; TAIPAI study group. Cardiovascular and
metabolic characters of <i>KCNJ5</i> somatic mutations in primary aldosteronism.
Front Endocrinol (Lausanne). 2023 Mar 6;14:1061704. doi:
10.3389/fendo.2023.1061704. PMID: 36950676; PMCID: PMC10025475.
21: Chen SY, Wu VC. Surgical versus medical treatment for unilateral primary
aldosteronism: an alternative to a randomized controlled trial. Eur J
Endocrinol. 2023 Mar 2;188(3):L3-L4. doi: 10.1093/ejendo/lvad021. PMID:
36757812.
22: Wu VC, Chan CK, Chueh JS, Chen YM, Lin YH, Chang CC, Lin PC, Chung SD;
TAIPAI group. Markers of Kidney Tubular Function Deteriorate While Those of
Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.
J Am Heart Assoc. 2023 Feb 21;12(4):e028146. doi: 10.1161/JAHA.122.028146. Epub
2023 Feb 15. PMID: 36789834; PMCID: PMC10111488.
23: Chiu CH, Hsuan CF, Lin SH, Hung YJ, Hwu CM, Hee SW, Lin SW, Fong SW, Hsieh
PC, Yang WS, Lin WC, Lee HL, Hsieh ML, Li WY, Lin JW, Hsu CN, Wu VC, Chuang GT,
Chang YC, Chuang LM. ER ribosomal-binding protein 1 regulates blood pressure and
potassium homeostasis by modulating intracellular renin trafficking. J Biomed
Sci. 2023 Feb 19;30(1):13. doi: 10.1186/s12929-023-00905-7. PMID: 36803854;
PMCID: PMC9940419.
24: Chen ZW, Pan CT, Liao CW, Tsai CH, Chang YY, Chang CC, Lee BC, Chiu YW,
Huang WC, Wang SM, Lu CC, Chueh JS, Wu VC, Hung CS, Lin YH. Implication of MR
Activity in Posttreatment Arterial Stiffness Reversal in Patients With Primary
Aldosteronism. J Clin Endocrinol Metab. 2023 Feb 15;108(3):624-632. doi:
10.1210/clinem/dgac649. Erratum in: J Clin Endocrinol Metab. 2022 Dec 13;: PMID:
36333943.
25: Chen UL, Liao CW, Wang SM, Lai TS, Huang KH, Chang CC, Lee BC, Lu CC, Chang
YR, Chang YY, Hung CS, Chueh JS, Wu VC, Tsai CH, Lin YH; TAIPAI study group.
Diabetes mellitus is associated with more adverse non-hemodynamic left
ventricular remodeling and less recovery in patients with primary aldosteronism.
J Investig Med. 2023 Feb;71(2):101-112. doi: 10.1177/10815589221141840. Epub
2023 Jan 16. PMID: 36647318.
26: Wu VC, Chan CK, Wu WC, Peng KY, Chang YS, Yeh FY, Chiang JY, Lee YJ, Liu KL,
Wang SM, Lin YH, Chueh JS; TAIPAI group. New-onset diabetes mellitus risk
associated with concurrent autonomous cortisol secretion in patients with
primary aldosteronism. Hypertens Res. 2023 Feb;46(2):445-455. doi:
10.1038/s41440-022-01086-w. Epub 2022 Dec 8. PMID: 36481967.
27: Kao TW, Wu XM, Liao CW, Tsai CH, Chen ZW, Chang YY, Lee BC, Chiu YW, Lai TS,
Wu VC, Lin YH, Hung CS; and theTAIPAI Study Group*. Anatomical and functional
remodeling of left ventricle in patients with primary aldosteronism and
concomitant albuminuria. Ther Adv Chronic Dis. 2023 Jan 18;14:20406223221143253.
doi: 10.1177/20406223221143253. PMID: 36860935; PMCID: PMC9969461.
28: Liao CW, Lin YT, Tsai CH, Chang YY, Chen ZW, Lu CC, Pan CT, Chang CC, Lee
BC, Chiu YW, Huang WC, Huang KH, Lai TS, Hung CS, Wu VC, Wu XM, Lin YH; TAIPAI
Study Group. Mineralocorticoid receptor antagonist treatment improved arterial
stiffness in patients with primary aldosteronism: a cohort study compared with
adrenalectomy. Ther Adv Chronic Dis. 2023 Jan 16;14:20406223221143233. doi:
10.1177/20406223221143233. PMID: 36687666; PMCID: PMC9846303.
29: Chen SY, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, Lin YH, Wu VC,
Study Group T. Cardiovascular outcomes and all-cause mortality in primary
aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist
treatment: a meta-analysis. Eur J Endocrinol. 2022 Nov 22;187(6):S47-S58. doi:
10.1530/EJE-22-0375. PMID: 36315466.
30: Wu VC, Peng KY, Hu YH, Chang CC, Chan CK, Lai TS, Lin YH, Wang SM, Lu CC,
Liu YC, Tsai YC, Chueh JS. Circulating Plasma Concentrations of ACE2 in Primary
Aldosteronism and Cardiovascular Outcomes. J Clin Endocrinol Metab. 2022 Nov
25;107(12):3242-3251. doi: 10.1210/clinem/dgac539. PMID: 36125178; PMCID:
PMC9494503.
31: Lu CC, Chen CJ, Peng KY, Chueh JS, Chang CC, Yen RF, Wu VC; Taiwan Primary
Aldosteronism Investigation (TAIPAI) Study Group. Predicting Treatment Response
in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
Clin Nucl Med. 2022 Nov 1;47(11):936-942. doi: 10.1097/RLU.0000000000004369.
Epub 2022 Aug 12. PMID: 36215396.
32: Williams TA, Gong S, Tsurutani Y, Tezuka Y, Thuzar M, Burrello J, Wu VC,
Yamazaki Y, Mulatero P, Sasano H, Stowasser M, Nishikawa T, Satoh F, Reincke M.
Adrenal surgery for bilateral primary aldosteronism: an international
retrospective cohort study. Lancet Diabetes Endocrinol. 2022 Nov;10(11):769-771.
doi: 10.1016/S2213-8587(22)00253-4. Epub 2022 Sep 19. PMID: 36137555.
33: Wu WC, Peng KY, Lu JY, Chan CK, Wang CY, Tseng FY, Yang WS, Lin YH, Lin PC,
Chen TC, Huang KH, Chueh JS, Wu VC. Cortisol-producing adenoma-related somatic
mutations in unilateral primary aldosteronism with concurrent autonomous
cortisol secretion: their prevalence and clinical characteristics. Eur J
Endocrinol. 2022 Sep 14;187(4):519-530. doi: 10.1530/EJE-22-0286. PMID:
35900323.
34: Huang WC, Lin YH, Wu VC, Chen CH, Siddique S, Chia YC, Tay JC, Sogunuru G,
Cheng HM, Kario K. Who should be screened for primary aldosteronism? A
comprehensive review of current evidence. J Clin Hypertens (Greenwich). 2022
Sep;24(9):1194-1203. doi: 10.1111/jch.14558. PMID: 36196469; PMCID: PMC9532923.
35: Pan HC, Chen YH, Fang WC, Wu VC, Sun CY. Essential Roles of the Histone
Demethylase KDM4C in Renal Development and Acute Kidney Injury. Int J Mol Sci.
2022 Aug 18;23(16):9318. doi: 10.3390/ijms23169318. PMID: 36012577; PMCID:
PMC9409075.
36: Lu YC, Liu KL, Wu VC, Wang SM, Lin YH, Chueh SJ, Wu KD, Huang KH; Taiwan
Primary Aldosteronism Investigation Study Group. Factors associated with renal
function change after unilateral adrenalectomy in patients with primary
aldosteronism. Int J Urol. 2022 Aug;29(8):831-837. doi: 10.1111/iju.14905. Epub
2022 Apr 26. PMID: 35474521.
37: Tseng CS, Peng KY, Wang SM, Tsai YC, Huang KH, Lin WC, Hu YH, Wu VC, Chueh
JS. A Novel Somatic Mutation of <i>CACNA1H</i> p.V1937M in Unilateral Primary
Hyperaldosteronism. Front Endocrinol (Lausanne). 2022 Jun 9;13:816476. doi:
10.3389/fendo.2022.816476. PMID: 35757409; PMCID: PMC9218183.
38: Tsai CH, Liao CW, Wu XM, Chen ZW, Pan CT, Chang YY, Lee BC, Shun CT, Wen WF,
Chou CH, Wu VC, Hung CS, Lin YH. Autonomous cortisol secretion is associated
with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a
cross-sectional study with follow-up data. Eur J Endocrinol. 2022 Jun
7;187(1):197-208. doi: 10.1530/EJE-21-1157. PMID: 35551115.
39: Chen PT, Chang D, Liu KL, Liao WC, Wang W, Chang CC, Wu VC, Lin YH.
Radiomics utilization to differentiate nonfunctional adenoma in essential
hypertension and functional adenoma in primary aldosteronism. Sci Rep. 2022 May
25;12(1):8892. doi: 10.1038/s41598-022-12835-9. PMID: 35614110; PMCID:
PMC9132956.
40: Peng SY, Tsai CH, Wu XM, Huang HH, Chen ZW, Lee BC, Chang YY, Pan CT, Wu VC,
Chou CH, Hung CS, Liao CW, Lin YH. Aldosterone Suppresses Endothelial
Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen
Species Pathway. Biomedicines. 2022 May 12;10(5):1119. doi:
10.3390/biomedicines10051119. PMID: 35625856; PMCID: PMC9138689.
41: Chang CM, Peng KY, Chan CK, Lin YF, Liao HW, Chang JG, Wu MS, Wu VC, Chang
WC. Divergent Characteristics of T-Cell Receptor Repertoire Between Essential
Hypertension and Aldosterone-Producing Adenoma. Front Immunol. 2022 May
10;13:853403. doi: 10.3389/fimmu.2022.853403. PMID: 35619691; PMCID: PMC9127864.
42: Chen YJ, Peng KY, Chueh JS, Liao HW, Hsieh TY, Wu VC, Wang SM. Case Report:
Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With
HISTALDO Classical and Contralateral Non-Classical Pathology. Front Endocrinol
(Lausanne). 2022 Mar 18;13:816754. doi: 10.3389/fendo.2022.816754. PMID:
35399924; PMCID: PMC8989467.
43: Lee BC, Kang VJ, Pan CT, Huang JZ, Lin YL, Chang YY, Tsai CH, Chou CH, Chen
ZW, Liao CW, Chiu YW, Wu VC, Hung CS, Chang CC, Lin YH. KCNJ5 Somatic Mutation
Is Associated With Higher Aortic Wall Thickness and Less Calcification in
Patients With Aldosterone-Producing Adenoma. Front Endocrinol (Lausanne). 2022
Mar 2;13:830130. doi: 10.3389/fendo.2022.830130. PMID: 35311227; PMCID:
PMC8924484.
44: Chang CK, Chang CC, Wu VC, Geng JH, Lee HY. The Relationship Between Renal
Stones and Primary Aldosteronism. Front Endocrinol (Lausanne). 2022 Feb
9;13:828839. doi: 10.3389/fendo.2022.828839. PMID: 35222284; PMCID: PMC8864315.
45: Pan HC, Huang TM, Sun CY, Chou NK, Tsao CH, Yeh FY, Lai TS, Chen YM, Wu VC.
Predialysis serum lactate levels could predict dialysis withdrawal in Type 1
cardiorenal syndrome patients. EClinicalMedicine. 2022 Jan 10;44:101232. doi:
10.1016/j.eclinm.2021.101232. PMID: 35059613; PMCID: PMC8760464.
46: Tsai CH, Wu XM, Liao CW, Chen ZW, Pan CT, Chang YY, Lee BC, Chiu YW, Lai TS,
Wu VC, Hung CS, Lin YH. Diabetes mellitus is associated with worse baseline and
less post-treatment recovery of arterial stiffness in patients with primary
aldosteronism. Ther Adv Chronic Dis. 2022 Jan 13;13:20406223211066727. doi:
10.1177/20406223211066727. PMID: 35070251; PMCID: PMC8771743.
47: Wu YC, Chen CI, Chen PY, Kuo CH, Hung YH, Peng KY, Wu VC, Tsai-Wu JJ, Hsu
CL; TAIPAI group. GRAde: a long-read sequencing approach to efficiently
identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-
remediable aldosteronism. BMC Bioinformatics. 2022 Jan 10;22(Suppl 10):613. doi:
10.1186/s12859-022-04561-w. PMID: 35012455; PMCID: PMC8750845.
48: Lin JH, Peng KY, Kuo YP, Liu H, Tan CB, Lin YF, Chiu HW, Lin YH, Chen YM,
Chueh JS, Wu VC. Aldosterone-producing nodules and CYP11B1 signaling correlate
in primary aldosteronism. Endocr Relat Cancer. 2022 Jan 10;29(2):59-69. doi:
10.1530/ERC-21-0287. PMID: 34821221.
49: Hung CS (啟盛) 628401, Chang YY, Tsai CH, Liao CW, Peng SY, Lee BC, Pan CT, Wu
XM, Chen ZW, Wu VC, Wan CH, Young MJ, Chou CH, Lin YH; TAIPAI Study Group.
Aldosterone suppresses cardiac mitochondria. Transl Res. 2022 Jan;239:58-70.
doi: 10.1016/j.trsl.2021.08.003. Epub 2021 Aug 16. PMID: 34411778.
50: Wu VC, Wang SM, Huang KH, Tsai YC, Chan CK, Yang SY, Lin LY, Chang CC, Lu
CC, Lin YH, Chen YM, Chueh JS. Long-term mortality and cardiovascular events in
patients with unilateral primary aldosteronism after targeted treatments. Eur J
Endocrinol. 2021 Dec 20;186(2):195-205. doi: 10.1530/EJE-21-0836. PMID:
34851859.
51: Cheng CY, Liao HW, Peng KY, Chen TH, Lin YH, Chueh JS, Wu VC, On Behalf Of
The Taipai Study Group. Characteristics and Outcomes in Primary Aldosteronism
Patients Harboring Glucocorticoid-Remediable Aldosteronism. Biomedicines. 2021
Dec 2;9(12):1816. doi: 10.3390/biomedicines9121816. PMID: 34944634; PMCID:
PMC8698750.
52: Wu VC, Peng KY, Kuo YP, Liu H, Tan BC, Lin YH, Lai TS, Chen YM, Chueh JS;
TAIPAI. Subtypes of Histopathologically Classical Aldosterone-Producing Adenomas
Yield Various Transcriptomic Signaling and Outcomes. Hypertension. 2021
Dec;78(6):1791-1800. doi: 10.1161/HYPERTENSIONAHA.121.18006. Epub 2021 Oct 18.
PMID: 34657444.
53: Chen KM, Chang YL, Wu TH, Lee BC, Chen PT, Liu KL, Hong JS, Chang CC, Wu VC,
Lin YH; TAIPAI Study Group. Aldosterone-producing adenoma-harbouring KCNJ5
mutations is associated with lower prevalence of metabolic disorders and
abdominal obesity. J Hypertens. 2021 Dec 1;39(12):2353-2360. doi:
10.1097/HJH.0000000000002948. PMID: 34313632.
54: Wu WC, Wei Q, Wu VC. Editorial: Diagnosis and Treatment of Primary
Aldosteronism: from Clinical Origin to Translational Research. Front Endocrinol
(Lausanne). 2021 Nov 30;12:781105. doi: 10.3389/fendo.2021.781105. PMID:
34917034; PMCID: PMC8669742.
55: Chan CK, Chang YY, Tsai YC, Chen ZW, Wu CY, Huang WC, Yen IW, Wu KH, Wu VC,
Lin YH; TAIPAI Study Group. Taiwan mini-frontier of primary aldosteronism:
Updating treatment and comorbidities detection. J Formos Med Assoc. 2021
Oct;120(10):1811-1820. doi: 10.1016/j.jfma.2021.03.032. Epub 2021 Apr 24. PMID:
33906783.
56: Chueh JS, Peng KY, Wu VC, Wang SM, Chan CK, Chen YM, Ke YY, Pan CY, Liao HW.
Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary
aldosteronism. J Mol Endocrinol. 2021 Sep 28;67(4):203-215. doi:
10.1530/JME-20-0282. PMID: 34463641.
57: Chen ZW, Pan CT, Tsai CH, Chang YY, Chang CC, Lee BC, Chiu YW, Huang WC, Lin
YL, Wu VC, Hung CS, Liao CW, Lin YH, On Behalf Of Taipai Study Group. Heart-
Ankle Pulse Wave Velocity Is Superior to Brachial-Ankle Pulse Wave Velocity in
Detecting Aldosterone-Induced Arterial Stiffness. Biomedicines. 2021 Sep
22;9(10):1285. doi: 10.3390/biomedicines9101285. PMID: 34680402; PMCID:
PMC8533381.
58: Liao HW, Peng KY, Wu VC, Lin YH, Lin SL, Lin WC, Chueh JS, On Behalf Of
Taipai Study Group. Characteristics of a Novel <i>ATP2B3</i> K416_F418delinsN
Mutation in a Classical Aldosterone-Producing Adenoma. Cancers (Basel). 2021 Sep
21;13(18):4729. doi: 10.3390/cancers13184729. PMID: 34572956; PMCID: PMC8472399.
59: Wu CH, Peng KY, Hwang DY, Lin YH, Wu VC, Chueh JS. Novel Mutations Detection
with Next-Generation Sequencing and Its Association with Clinical Outcome in
Unilateral Primary Aldosteronism. Biomedicines. 2021 Sep 6;9(9):1167. doi:
10.3390/biomedicines9091167. PMID: 34572353; PMCID: PMC8471673.
60: Chen CW, Tsai CH, Hung CS, Tsai IJ, Chiu YW, Chang CC, Liu KL, Liao SC, Wu
VC, Lin YH. Comparison of cystatin C-based and creatinine-based glomerular
filtration rate in the prediction of postoperative residual hypertension in
aldosterone-producing adenoma patients after adrenalectomy. Clin Chim Acta. 2021
Sep;520:147-153. doi: 10.1016/j.cca.2021.06.010. Epub 2021 Jun 9. PMID:
34116005.
61: Chang YY, Pan CT, Chen ZW, Tsai CH, Peng SY, Chang CC, Lee BC, Liao CW, Peng
KY, Chiu YW, Chou CH, Wu VC, Liu LD, Hung CS, Lin YH. <i>KCNJ5</i> Somatic
Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater
Recovery of Arterial Stiffness. Cancers (Basel). 2021 Aug 26;13(17):4313. doi:
10.3390/cancers13174313. PMID: 34503121; PMCID: PMC8431463.
62: Peng KY, Liao HW, Chueh JS, Pan CY, Lin YH, Chen YM, Chen PY, Huang CL, Wu
VC. Pathophysiological and Pharmacological Characteristics of <i>KCNJ5</i>
157-159delITE Somatic Mutation in Aldosterone-Producing Adenomas. Biomedicines.
2021 Aug 17;9(8):1026. doi: 10.3390/biomedicines9081026. PMID: 34440230; PMCID:
PMC8391641.
63: Tsai CH, Pan CT, Chang YY, Peng SY, Lee PC, Liao CW, Shun CT, Li PT, Wu VC,
Chou CH, Tsai IJ, Hung CS, Lin YH. Aldosterone Excess Induced Mitochondria
Decrease and Dysfunction via Mineralocorticoid Receptor and Oxidative Stress In
Vitro and In Vivo. Biomedicines. 2021 Aug 2;9(8):946. doi:
10.3390/biomedicines9080946. PMID: 34440149; PMCID: PMC8392669.
64: Chen JY, Tsai IJ, Pan HC, Liao HW, Neyra JA, Wu VC, Chueh JS. The Impact of
Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on
Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and
Meta-Analysis. Front Pharmacol. 2021 Jul 20;12:665250. doi:
10.3389/fphar.2021.665250. PMID: 34354583; PMCID: PMC8329451.
65: Lee MJ, Wu VC, Chueh JS. Authors' response to a letter to the Editor from
Zhu <i>et al.</i> re: Urinary sodium potassium ratio is associated with clinical
success after adrenalectomy in patients with unilateral primary aldosteronism.
Ther Adv Chronic Dis. 2021 Jul 7;12:20406223211029615. doi:
10.1177/20406223211029615. PMID: 34285791; PMCID: PMC8267027.
66: Lee MJ, Sun CY, Lu CC, Chang YS, Pan HC, Lin YH, Wu VC, Chueh JS. Urinary
sodium potassium ratio is associated with clinical success after adrenalectomy
in patients with unilateral primary aldosteronism. Ther Adv Chronic Dis. 2021
Feb 12;12:2040622321990274. doi: 10.1177/2040622321990274. PMID: 33633824;
PMCID: PMC7887682.
67: Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC, Hung CS, Lin YH. Left ventricular
remodeling and dysfunction in primary aldosteronism. J Hum Hypertens. 2021
Feb;35(2):131-147. doi: 10.1038/s41371-020-00426-y. Epub 2020 Oct 16. PMID:
33067554; PMCID: PMC7895762.
68: Chang YY, Tsai CH, Peng SY, Chen ZW, Chang CC, Lee BC, Liao CW, Pan CT, Chen
YL, Lin LC, Chang YR, Peng KY, Chou CH, Wu VC, Hung CS, Lin YH; TAIPAI Study
Group. <i>KCNJ5</i> Somatic Mutations in Aldosterone-Producing Adenoma Are
Associated With a Worse Baseline Status and Better Recovery of Left Ventricular
Remodeling and Diastolic Function. Hypertension. 2021 Jan;77(1):114-125. doi:
10.1161/HYPERTENSIONAHA.120.15679. Epub 2020 Nov 30. PMID: 33249859.
69: Chang CC, Chen YY, Lai TS, Zeng YH, Chen CK, Tu KH, Lu CC, Wu VC, Er LK;
TAIPAI Study Group. Taiwan mini-frontier of primary aldosteronism: Updating
detection and diagnosis. J Formos Med Assoc. 2021 Jan;120(1 Pt 1):121-129. doi:
10.1016/j.jfma.2020.08.001. Epub 2020 Aug 24. PMID: 32855034.
70: Chen YT, Chan CK, Li WY, Huang TM, Lai TS, Wu VC, Chu TS; National Taiwan
University Hospital Study Group on Acute Renal Failure (NSARF). Renin-
angiotensin-aldosterone system inhibition decreased contrast-associated acute
kidney injury in chronic kidney disease patients. J Formos Med Assoc. 2021
Jan;120(1 Pt 3):641-650. doi: 10.1016/j.jfma.2020.07.022. Epub 2020 Aug 3. PMID:
32762878.
71: Lin YF, Peng KY, Chang CH, Hu YH, Wu VC, Chung SD; Taiwan Primary
Aldosteronism Investigation (TAIPAI) Study Group. Changes in Glucose Metabolism
after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist
for Primary Aldosteronism. Endocrinol Metab (Seoul). 2020 Dec;35(4):838-846.
doi: 10.3803/EnM.2020.797. Epub 2020 Dec 2. PMID: 33261310; PMCID: PMC7803597.
72: Peng KY, Liao HW, Chan CK, Lin WC, Yang SY, Tsai YC, Huang KH, Lin YH, Chueh
JS, Wu VC. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-
Producing Adenomas Predicts Lower Clinical Success. Hypertension. 2020
Nov;76(5):1537-1544. doi: 10.1161/HYPERTENSIONAHA.120.15328. Epub 2020 Sep 14.
PMID: 32921192.
73: Chan CK, Huang YS, Liao HW, Tsai IJ, Sun CY, Pan HC, Chueh JS, Wang JT, Wu
VC, Chu TS; National Taiwan University Hospital Study Group of ARF, the Taiwan
Primary Aldosteronism Investigators and the Taiwan Consortium for Acute Kidney
Injury and Renal Diseases. Renin-Angiotensin-Aldosterone System Inhibitors and
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic
Review and Meta-Analysis. Hypertension. 2020 Nov;76(5):1563-1571. doi:
10.1161/HYPERTENSIONAHA.120.15989. Epub 2020 Sep 1. PMID: 32869673; PMCID:
PMC7485525.
74: Chan CK, Yang WS, Lin YH, Huang KH, Lu CC, Hu YH, Wu VC, Chueh JS, Chu TS,
Chen YM. Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal
Injury in Lateralized Primary Aldosteronism. J Clin Endocrinol Metab. 2020 Nov
1;105(11):dgaa566. doi: 10.1210/clinem/dgaa566. PMID: 32835357.
75: Liao HW, Wang SM, Chan CK, Lin YH, Lin PC, Ho CH, Liu YC, Chueh JS, Wu VC.
Transtubular potassium gradient predicts kidney function impairment after
adrenalectomy in primary aldosteronism. Ther Adv Chronic Dis. 2020 Aug
27;11:2040622320944792. doi: 10.1177/2040622320944792. PMID: 32922714; PMCID:
PMC7457632.
76: Er LK, Lin MC, Tsai YC, Hsiao JK, Yang CY, Chang CC, Peng KY, Chueh JS, Wu
VC; TAIPAI Study Group. Association of visceral adiposity and clinical outcome
among patients with aldosterone producing adenoma. BMJ Open Diabetes Res Care.
2020 Jul;8(1):e001153. doi: 10.1136/bmjdrc-2019-001153. PMID: 32713841; PMCID:
PMC7383952.
77: Huang CW, Lee BC, Liu KL, Chang YC, Wu VC, Lee PT, Chang CC; TAIPAI Study
Group. Preoperative non-stimulated adrenal venous sampling index for predicting
outcomes of adrenalectomy for unilateral primary aldosteronism. J Formos Med
Assoc. 2020 Jul;119(7):1185-1192. doi: 10.1016/j.jfma.2020.04.016. Epub 2020 May
5. PMID: 32386674.
78: Pan CT, Tsai CH, Chen ZW, Chang YY, Wu VC, Hung CS, Lin YH; TAIPAI Study
Group. Atrial Fibrillation in Primary Aldosteronism. Horm Metab Res. 2020
Jun;52(6):357-365. doi: 10.1055/a-1141-5989. Epub 2020 Apr 14. PMID: 32289838.
79: Wu VC, Chueh JS, Hsieh MY, Hu YH, Huang KH, Lin YH, Yang SY, Chu TS, Kuo CF.
Familial Aggregation and Heritability of Aldosteronism with Cardiovascular
Events. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgz257. doi:
10.1210/clinem/dgz257. PMID: 32193536.
80: Lin YF, Peng KY, Chang CH, Hu YH, Wu VC, Chueh JS. Response to Letter to the
Editor: "Adrenalectomy Completely Cured Hypertension in Familial
Hyperaldosteronism Type I Patients with Somatic KCNJ5 Mutation". J Clin
Endocrinol Metab. 2020 May 1;105(5):dgz110. doi: 10.1210/clinem/dgz110. PMID:
31634403.
81: Er LK, Chen L, Tsai YC, Lin YH, Huang WC, Chang CC, Lu CC, Huang KH, Chueh
JS, Wu KD, Wu VC; TAIPAI Study Group. Risk of new-onset autoimmune diseases in
primary aldosteronism: a nation-wide population-based study. J Hypertens. 2020
Apr;38(4):745-754. doi: 10.1097/HJH.0000000000002300. PMID: 31764584.
82: Pan CT, Liao CW, Tsai CH, Chen ZW, Chen L, Hung CS, Liu YC, Lin PC, Chang
CC, Chang YY, Wu VC, Lin YH; TAIPAI study group †. Influence of Different
Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With
Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study. J Am Heart
Assoc. 2020 Mar 3;9(5):e013699. doi: 10.1161/JAHA.119.013699. Epub 2020 Feb 19.
PMID: 32070205; PMCID: PMC7335564.
83: Liao CW, Chou CH, Wu XM, Chen ZW, Chen YH, Chang YY, Wu VC, Rose-John S,
Hung CS, Lin YH; TAIPAI Study Group. Interleukin-6 plays a critical role in
aldosterone-induced macrophage recruitment and infiltration in the myocardium.
Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165627. doi:
10.1016/j.bbadis.2019.165627. Epub 2019 Nov 28. PMID: 31785407.
84: Chang YH, Chung SD, Wu CH, Chueh JS, Chen L, Lin PC, Lin YH, Huang KH, Wu
VC, Chu TS; TAIPAI Study Group. Surgery decreases the long-term incident stroke
risk in patients with primary aldosteronism. Surgery. 2020 Feb;167(2):367-377.
doi: 10.1016/j.surg.2019.08.017. Epub 2019 Oct 29. PMID: 31676114.
85: Liao MT, Liao CW, Tsai CH, Chang YY, Chen ZW, Pan CT, Lin LC, Wu VC, Kuo SF,
Wu XM, Hung CS, Lin YH; TAIPAI study group. U-shaped relationship between left
ventricular mass index and estimated glomerular filtration rate in patients with
primary aldosteronism. J Investig Med. 2020 Feb;68(2):371-377. doi:
10.1136/jim-2019-001057. Epub 2019 Oct 19. PMID: 31630138.
86: Huang WC, Chen YY, Lin YH, Chen L, Lin PC, Lin YF, Liu YC, Wu CH, Chueh JS,
Chu TS, Wu KD, Huang CY, Wu VC; TAIPAI Study Group †; TAIPAI Study Group<xref
ref-type="author-note" rid="jah34540-note-1002"><sup>†</sup></xref>. Incidental
Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas. J Am
Heart Assoc. 2019 Dec 17;8(24):e012410. doi: 10.1161/JAHA.119.012410. Epub 2019
Dec 5. PMID: 31801414; PMCID: PMC6951059.
87: Buffolo F, Li Q, Monticone S, Heinrich DA, Mattei A, Pieroni J, Mei M, Yang
S, Hu YH, Yang MC, Sabbadin C, Pizzolo F, Giacchetti G, Fallo F, Veglio F,
Reincke M, Wu VC, Mulatero P. Primary Aldosteronism and Obstructive Sleep Apnea:
A Cross-Sectional Multi-Ethnic Study. Hypertension. 2019 Dec;74(6):1532-1540.
doi: 10.1161/HYPERTENSIONAHA.119.13833. Epub 2019 Nov 4. PMID: 31679423.
88: Chang YY, Liao CW, Tsai CH, Chen CW, Pan CT, Chen ZW, Chen YL, Lin LC, Chang
YR, Wu VC, Wu KD, Hung CS, Lin YH; TAIPAI Study Group* †; TAIPAI Study
Group*<xref ref-type="author-note" rid="jah34587-note-0001"><sup>†</sup></xref>.
Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A
Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging. J Am
Heart Assoc. 2019 Nov 19;8(22):e013263. doi: 10.1161/JAHA.119.013263. Epub 2019
Nov 13. PMID: 31718437; PMCID: PMC6915298.
89: Lin YF, Peng KY, Chang CH, Hu YH, Wu VC, Chueh JS, Wu KD. Adrenalectomy
Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type
I Who Had Somatic KCNJ5 Mutation. J Clin Endocrinol Metab. 2019 Nov
1;104(11):5462-5466. doi: 10.1210/jc.2019-00689. PMID: 31287546.
90: Chen ZW, Tsai CH, Pan CT, Chou CH, Liao CW, Hung CS, Wu VC, Lin YH; TAIPAI
Study Group. Endothelial Dysfunction in Primary Aldosteronism. Int J Mol Sci.
2019 Oct 21;20(20):5214. doi: 10.3390/ijms20205214. PMID: 31640178; PMCID:
PMC6829211.
91: Wu CH, Wu V, Yang YW, Lin YH, Yang SY, Lin PC, Chang CC, Tsai YC, Wang SM;
TAIPAI group. Plasma Aldosterone After Seated Saline Infusion Test Outperforms
Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary
Aldosteronism. Am J Hypertens. 2019 Oct 16;32(11):1066-1074. doi:
10.1093/ajh/hpz098. PMID: 31216359.
92: Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C,
Widimsky J Jr, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E,
Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller
PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Dun Wu
K, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina
AC. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With
Adrenal Vein Sampling. Hypertension. 2019 Oct;74(4):800-808. doi:
10.1161/HYPERTENSIONAHA.119.13463. Epub 2019 Sep 3. PMID: 31476901.
93: Hung CS, Sung SH, Liao CW, Pan CT, Chang CC, Chen ZW, Wu VC, Chen CH, Cheng
HM, Lin YH; TAIPAI Study Group. Aldosterone Induces Vascular Damage.
Hypertension. 2019 Sep;74(3):623-629. doi: 10.1161/HYPERTENSIONAHA.118.12342.
Epub 2019 Jul 29. PMID: 31352825.
94: Chan CK, Kim JH, Chueh E, Chang CC, Lin YF, Lai TS, Huang KH, Lin YH, Wu VC;
TAIPAI Study Group. Aldosterone level after saline infusion test could predict
clinical outcome in primary aldosteronism after adrenalectomy. Surgery. 2019
Sep;166(3):362-368. doi: 10.1016/j.surg.2019.05.001. Epub 2019 Jun 15. PMID:
31208863.
95: Chen YY, Lin YH, Huang WC, Chueh E, Chen L, Yang SY, Lin PC, Lin LY, Lin YH,
Wu VC, Chu TS, Wu KD. Adrenalectomy Improves the Long-Term Risk of End-Stage
Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc. 2019 Mar
25;3(6):1110-1126. doi: 10.1210/js.2019-00019. PMID: 31086833; PMCID:
PMC6507624.
96: Chang CH, Chueh SJ, Wu VC, Chen L, Lin YH, Hu YH, Wu KD, Tsai YC. Risk of
severe erectile dysfunction in primary hyperaldosteronism: A population-based
propensity score matching cohort study. Surgery. 2019 Mar;165(3):622-628. doi:
10.1016/j.surg.2018.08.020. Epub 2018 Nov 23. PMID: 30473204.
97: Lin YF, Chen L, Lin SL, Yeh YC, Huang TM, Chou YH, Chang FC, Chen YT, Yang
SY, Lai TS, Wu VC, Chu TS, Wu KD; National Taiwan University Hospital Study
Group on Acute Renal Failure (NSARF), Taiwan Primary Aldosteronism Investigation
(TAIPAI) Study Group. Potential target-organ protection of mineralocorticoid
receptor antagonist in acute kidney disease. J Hypertens. 2019
Jan;37(1):125-134. doi: 10.1097/HJH.0000000000001876. PMID: 30063639.
98: Chen KT, Wu VC, Wu KD, Huang KH. Is prophylactic nasogastric tube
decompression necessary in patients undergoing laparoscopic adrenalectomy for
unilateral benign adrenal tumor. J Formos Med Assoc. 2019 Jan;118(1 Pt
3):401-405. doi: 10.1016/j.jfma.2018.06.019. Epub 2018 Jul 11. PMID: 30006232.
99: Huang KH, Yu CC, Hu YH, Chang CC, Chan CK, Liao SC, Tsai YC, Jeff Chueh SC,
Wu VC, Lin YH; TAIPAI, Taiwan Primary Aldosteronism Investigator. Targeted
treatment of primary aldosteronism - The consensus of Taiwan Society of
Aldosteronism. J Formos Med Assoc. 2019 Jan;118(1 Pt 1):72-82. doi:
10.1016/j.jfma.2018.01.006. Epub 2018 Mar 3. PMID: 29506889.
100: Chan CK, Hu YH, Chen L, Chang CC, Lin YF, Lai TS, Huang KH, Lin YH, Wu VC,
Wu KD; TAIPAI Study Group. Risk of sepsis in patients with primary
aldosteronism. Crit Care. 2018 Nov 21;22(1):313. doi: 10.1186/s13054-018-2239-y.
PMID: 30463626; PMCID: PMC6249889.
101: Lin JH, Lin YF, Wang WJ, Lin YF, Chueh SJ, Wu VC, Chu TS, Wu KD; Taiwan
Primary Aldosteronism Investigation (TAIPAI) Study Group. Plasma Aldosterone
Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive
Patients for Atherosclerotic Cardiovascular Disease. J Clin Med. 2018 Oct
24;7(11):382. doi: 10.3390/jcm7110382. PMID: 30355992; PMCID: PMC6262476.
102: Chang CH, Hu YH, Huang KH, Lin YH, Tsai YC, Wu CH, Yang SY, Chang CC, Lu
CC, Wu KD, Wu VC. Higher Screening Aldosterone to Renin Ratio in Primary
Aldosteronism Patients with Diabetes Mellitus. J Clin Med. 2018 Oct
16;7(10):360. doi: 10.3390/jcm7100360. PMID: 30332741; PMCID: PMC6209946.
103: Peng KY, Chang HM, Lin YF, Chan CK, Chang CH, Chueh SJ, Yang SY, Huang KH,
Lin YH, Wu VC, Wu KD. miRNA-203 Modulates Aldosterone Levels and Cell
Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas. J Clin
Endocrinol Metab. 2018 Oct 1;103(10):3737-3747. doi: 10.1210/jc.2018-00746.
PMID: 30085132.
104: Chang CH, Yang SS, Tsai YC, Kuo SW, Cherng SC, Lu CC, Yen RF, Wu VC, Hu YH.
Surgical outcomes of patients with primary aldosteronism lateralized with
I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography
without discontinuation or modification of antihypertensive medications. Ci Ji
Yi Xue Za Zhi. 2018 Jul-Sep;30(3):169-175. doi: 10.4103/tcmj.tcmj_106_17. PMID:
30069126; PMCID: PMC6047325.
105: Chou CH, Hung CS, Liao CW, Wei LH, Chen CW, Shun CT, Wen WF, Wan CH, Wu XM,
Chang YY, Wu VC, Wu KD, Lin YH; TAIPAI Study Group. IL-6 trans-signalling
contributes to aldosterone-induced cardiac fibrosis. Cardiovasc Res. 2018 Apr
1;114(5):690-702. doi: 10.1093/cvr/cvy013. PMID: 29360942.
106: Chen ZW, Wu VC, Lin YH; TAIPAI study group. Reply. J Hypertens. 2018
Mar;36(3):701-702. doi: 10.1097/HJH.0000000000001643. PMID: 29384989.
107: Chang CC, Lee BC, Liu KL, Chang YC, Wu VC, Huang KH, Wu TH. The influence
of the peripheral cortisol fluctuation on the success rate of adrenal venous
sampling. Sci Rep. 2018 Feb 8;8(1):2664. doi: 10.1038/s41598-018-20647-z. PMID:
29422627; PMCID: PMC5805749.
108: Er LK, Wu VC; TAIPAI Study Group. Call for screening for primary
aldosteronism: an underdiagnosed and treatable disease. J Thorac Dis. 2018
Feb;10(2):557-559. doi: 10.21037/jtd.2018.01.71. PMID: 29607111; PMCID:
PMC5864689.
109: Chen ZW, Huang KC, Lee JK, Lin LC, Chen CW, Chang YY, Liao CW, Wu VC, Hung
CS, Lin YH; TAIPAI study group. Aldosterone induces left ventricular subclinical
systolic dysfunction: a strain imaging study. J Hypertens. 2018
Feb;36(2):353-360. doi: 10.1097/HJH.0000000000001534. PMID: 28902663.
110: Chan CK, Lai TS, Wu V; TAIPAI Study Group. Reply. J Hypertens. 2017
Dec;35(12):2549-2550. doi: 10.1097/HJH.0000000000001549. PMID: 29095233.
111: Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, Lu CC, Chang CC, Lin JH,
Lin YH, Wang TD, Wang CY, Tu ST, Jeff Chueh SC, Chang CC, Tseng FY, Wu KD;
TAIPAI group. Case detection and diagnosis of primary aldosteronism - The
consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2017
Dec;116(12):993-1005. doi: 10.1016/j.jfma.2017.06.004. Epub 2017 Jul 20. PMID:
28735660.
112: Chang CC, Lee BC, Chang YC, Wu VC, Huang KH, Liu KL; TAIPAI Study Group.
Comparison of C-arm computed tomography and on-site quick cortisol assay for
adrenal venous sampling: A retrospective study of 178 patients. Eur Radiol. 2017
Dec;27(12):5006-5014. doi: 10.1007/s00330-017-4930-9. Epub 2017 Jul 4. PMID:
28677050.
113: Wu VC, Wu CH, Yang YW, Huang KH, Chang CH, Yang SY, Lin YH, Wu KD; NRPB
Kidney Consortium. The therapeutic effect of bromocriptine in combination with
spironolactone in patients with primary aldosteronism: a hypothesis generating
pilot study. Oncotarget. 2017 Sep 6;8(44):77609-77621. doi:
10.18632/oncotarget.20670. PMID: 29100412; PMCID: PMC5652803.
114: Hung CS, Wu XM, Chen CW, Chen YH, Wu VC, Liao CW, Chang YY, Yen RF, Lu CC,
Su MM, Liu KL, Chang CC, Liu LD, Wu KD, Lin YH; TAIPAI Study Group. The
relationship among cardiac structure, dietary salt and aldosterone in patients
with primary aldosteronism. Oncotarget. 2017 Apr 28;8(42):73187-73197. doi:
10.18632/oncotarget.17505. PMID: 29069862; PMCID: PMC5641205.
115: Wu VC, Chueh SJ, Chen L, Chang CH, Hu YH, Lin YH, Wu KD, Yang WS; TAIPAI
Study Group. Risk of new-onset diabetes mellitus in primary aldosteronism: a
population study over 5 years. J Hypertens. 2017 Aug;35(8):1698-1708. doi:
10.1097/HJH.0000000000001361. PMID: 28661412.
116: Chang CH, Hu YH, Tsai YC, Wu CH, Wang SM, Lin LY, Lin YH, Satoh F, Wu KD,
Wu VC. Arterial stiffness and blood pressure improvement in aldosterone-
producing adenoma harboring KCNJ5 mutations after adrenalectomy. Oncotarget.
2017 May 2;8(18):29984-29995. doi: 10.18632/oncotarget.16269. PMID: 28415786;
PMCID: PMC5444719.
117: Wu VC, Chang CH, Wang CY, Lin YH, Kao TW, Lin PC, Chu TS, Chang YS, Chen L,
Wu KD, Chueh SJ. Risk of Fracture in Primary Aldosteronism: A Population-Based
Cohort Study. J Bone Miner Res. 2017 Apr;32(4):743-752. doi: 10.1002/jbmr.3033.
Epub 2017 Feb 14. PMID: 27862274.
118: Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SJ, Chen L, Wu KD.
Corrigendum: Long term outcome of Aldosteronism after target treatments. Sci
Rep. 2017 Mar 24;7:45249. doi: 10.1038/srep45249. Erratum for: Sci Rep. 2016 Sep
02;6:32103. PMID: 28338668; PMCID: PMC5365036.
119: Wu VC, Wang SM, Chueh SJ, Yang SY, Huang KH, Lin YH, Wang JJ, Connolly R,
Hu YH, Gomez-Sanchez CE, Peng KY, Wu KD. The prevalence of CTNNB1 mutations in
primary aldosteronism and consequences for clinical outcomes. Sci Rep. 2017 Jan
19;7:39121. doi: 10.1038/srep39121. PMID: 28102204; PMCID: PMC5244399.
120: Chang CC, Lee BC, Liu KL, Chang YC, Wu VC, Huang KH. Non-stimulated adrenal
venous sampling using Dyna computed tomography in patients with primary
aldosteronism. Sci Rep. 2016 Nov 23;6:37143. doi: 10.1038/srep37143. PMID:
27876824; PMCID: PMC5120298.
121: Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SC, Chen L, Wu KD.
Long term outcome of Aldosteronism after target treatments. Sci Rep. 2016 Sep
2;6:32103. doi: 10.1038/srep32103. Erratum in: Sci Rep. 2017 Mar 24;7:45249.
PMID: 27586402; PMCID: PMC5009379.
122: Liao CW, Lin YT, Wu XM, Chang YY, Hung CS, Wu VC, Wu KD, Lin YH; TAIPAI
Study Group. The relation among aldosterone, galectin-3, and myocardial
fibrosis: a prospective clinical pilot follow-up study. J Investig Med. 2016
Aug;64(6):1109-13. doi: 10.1136/jim-2015-000014. Epub 2016 May 17. PMID:
27190071.
123: Lee BC, Chang CC, Liu KL, Chang YC, Wu VC, Huang KH. Evaluation of right
adrenal vein anatomy by Dyna computed tomography in patients with primary
aldosteronism. Sci Rep. 2016 Jun 23;6:28305. doi: 10.1038/srep28305. PMID:
27334209; PMCID: PMC4917856.
124: Hung CS, Chou CH, Liao CW, Lin YT, Wu XM, Chang YY, Chen YH, Wu VC, Su MJ,
Ho YL, Chen MF, Wu KD, Lin YH; TAIPAI Study Group*. Aldosterone Induces Tissue
Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen
Accumulation: From Clinical to Bench Studies. Hypertension. 2016
Jun;67(6):1309-20. doi: 10.1161/HYPERTENSIONAHA.115.06768. Epub 2016 Apr 25.
PMID: 27113051.
125: Liao CW, Lin LY, Hung CS, Lin YT, Chang YY, Wang SM, Wu VC, Wu KD, Ho YL,
Satoh F, Lin YH. Time course and factors predicting arterial stiffness reversal
in patients with aldosterone-producing adenoma after adrenalectomy: prospective
study of 102 patients. Sci Rep. 2016 Feb 17;6:20862. doi: 10.1038/srep20862.
PMID: 26883298; PMCID: PMC4756682.
126: Chou CH, Chen YH, Hung CS, Chang YY, Tzeng YL, Wu XM, Wu VC, Tsai CT, Wu
CK, Ho YL, Wu KD, Lin YH; TAIPAI Study Group. Aldosterone Impairs Vascular
Smooth Muscle Function: From Clinical to Bench Research. J Clin Endocrinol
Metab. 2015 Nov;100(11):4339-47. doi: 10.1210/jc.2015-2752. Epub 2015 Sep 24.
PMID: 26401591.
127: Wu CH, Yang YW, Hung SC, Tsai YC, Hu YH, Lin YH, Chu TS, Wu KD, Wu VC.
Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone
Producing Adenoma: Adrenalectomy versus Spironolactone. Sci Rep. 2015 Oct
19;5:15297. doi: 10.1038/srep15297. PMID: 26477337; PMCID: PMC4609981.
128: Hung CS, Chou CH, Wu XM, Chang YY, Wu VC, Chen YH, Chang YS, Tsai YC, Su
MJ, Ho YL, Chen MF, Wu KD, Lin YH; TAIPAI Study Group. Circulating tissue
inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced
diastolic dysfunction. J Hypertens. 2015 Sep;33(9):1922-30; discussion 1930.
doi: 10.1097/HJH.0000000000000619. PMID: 26103125.
129: Kuo CC, Balakrishnan P, Hsein YC, Wu VC, Chueh SC, Chen YM, Wu KD, Wang MJ;
TAIPAI group. The value of losartan suppression test in the confirmatory
diagnosis of primary aldosteronism in patients over 50 years old. J Renin
Angiotensin Aldosterone Syst. 2015 Sep;16(3):587-98. doi:
10.1177/1470320313498632. Epub 2014 Jul 16. PMID: 25031295; PMCID: PMC4297265.
130: Lin YH, Wu VC, Lo MT, Wu XM, Hung CS, Wu KD, Lin C, Ho YL, Stowasser M,
Peng CK. Reversible heart rhythm complexity impairment in patients with primary
aldosteronism. Sci Rep. 2015 Aug 18;5:11249. doi: 10.1038/srep11249. PMID:
26282603; PMCID: PMC4539539.
131: Liao CW, Chen A, Lin YT, Chang YY, Wang SM, Wu VC, Hung CS, Wu KD, Chueh
SC, Lin YH; TAIPAI Study Group. The Relation Between the Degree of Left
Ventricular Mass Regression and Serum Potassium Level Change in Patients With
Primary Aldosteronism After Adrenalectomy. J Investig Med. 2015
Aug;63(6):816-20. doi: 10.1097/JIM.0000000000000215. PMID: 26083251.
132: Wu VC, Huang KH, Peng KY, Tsai YC, Wu CH, Wang SM, Yang SY, Lin LY, Chang
CC, Lin YH, Lin SL, Chu TS, Wu KD. Prevalence and clinical correlates of somatic
mutation in aldosterone producing adenoma-Taiwanese population. Sci Rep. 2015
Jun 12;5:11396. doi: 10.1038/srep11396. PMID: 26066391; PMCID: PMC4464349.
133: Chang YY, Chen A, Chen YH, Hung CS, Wu VC, Wu XM, Lin YH, Ho YL, Wu KD;
TAIPAI Study Group. Hypokalemia correlated with arterial stiffness but not
microvascular endothelial function in patients with primary aldosteronism. J
Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):353-9. doi:
10.1177/1470320314524996. Epub 2014 Aug 20. PMID: 25143326.
134: Liao MT, Wu XM, Chang CC, Liao CW, Chen YH, Lu CC, Lin YT, Chang YY, Hung
CS, Lin LC, Lai CL, Lin LY, Wu VC, Ho YL, Wu KD, Lin YH; TAIPAI Study Group. The
Association between Glomerular Hyperfiltration and Left Ventricular Structure
and Function in Patients with Primary Aldosteronism. Int J Med Sci. 2015 May
3;12(5):369-77. doi: 10.7150/ijms.10975. PMID: 26005371; PMCID: PMC4441061.
135: Chen AH, Li HY, Wu VC, Lin YH, Huang TS; Taiwan Primary Aldosteronism
Investigation (TAIPAI) Study Group. Serum dehydroepiandrosterone sulfate
concentration is lower in women with primary aldosteronism. J Renin Angiotensin
Aldosterone Syst. 2015 Mar;16(1):137-44. doi: 10.1177/1470320313483843. Epub
2013 Apr 9. PMID: 23571826.
136: Kao CC, Wu CH, Lin YH, Chang CC, Chen HH, Wu MS, Wu VC, Wu KD; TAIPAI Study
Group. Risk of ischemic stroke in primary aldosteronism patients. Clin Chim
Acta. 2015 Jan 1;438:86-9. doi: 10.1016/j.cca.2014.08.007. Epub 2014 Aug 11.
PMID: 25124866.
137: Wu VC, Hu YH, Wu CH, Kao CC, Wang CY, Yang WS, Lee HH, Chang YS, Lin YH,
Wang SM, Chen L, Wu KD; TAIPAI Study Group. Administrative data on diagnosis and
mineralocorticoid receptor antagonist prescription identified patients with
primary aldosteronism in Taiwan. J Clin Epidemiol. 2014 Oct;67(10):1139-49. doi:
10.1016/j.jclinepi.2014.05.012. Epub 2014 Jul 14. PMID: 25034196.
138: Lin YH, Chou CH, Wu XM, Chang YY, Hung CS, Chen YH, Tzeng YL, Wu VC, Ho YL,
Hsieh FJ, Wu KD; TAIPAI Study Group. Aldosterone induced galectin-3 secretion in
vitro and in vivo: from cells to humans. PLoS One. 2014 Sep 2;9(9):e95254. doi:
10.1371/journal.pone.0095254. PMID: 25180794; PMCID: PMC4152338.
139: Chang YY, Lee HH, Hung CS, Wu XM, Lee JK, Wang SM, Liao MT, Chen YH, Wu VC,
Wu KD, Lin YH; TAIPAI Study Group. Association between urine aldosterone and
diastolic function in patients with primary aldosteronism and essential
hypertension. Clin Biochem. 2014 Sep;47(13-14):1329-32. doi:
10.1016/j.clinbiochem.2014.05.062. Epub 2014 Jun 2. PMID: 24892901.
140: Chen SF, Chueh SC, Wang SM, Wu VC, Pu YS, Wu KD, Huang KH. Clinical
outcomes in patients undergoing laparoscopic adrenalectomy for unilateral
aldosterone producing adenoma: partial versus total adrenalectomy. J Endourol.
2014 Sep;28(9):1103-6. doi: 10.1089/end.2014.0102. Epub 2014 Jun 30. PMID:
24828761.
141: Lu CC, Wu VC, Wu KD, Liu KL, Lin WC, Cheng MF, Tzen KY, Yen RF; TAIPAI
Study Group. Prognostic value of semiquantification NP-59 SPECT/CT in primary
aldosteronism patients after adrenalectomy. Eur J Nucl Med Mol Imaging. 2014
Jul;41(7):1375-84. doi: 10.1007/s00259-014-2692-z. Epub 2014 Feb 14. PMID:
24525587.
142: Chang HW, Huang CY, Yang SY, Wu VC, Chu TS, Chen YM, Hsieh BS, Wu KD. Role
of D2 dopamine receptor in adrenal cortical cell proliferation and aldosterone-
producing adenoma tumorigenesis. J Mol Endocrinol. 2014 Jan 30;52(2):87-96. doi:
10.1530/JME-13-0044. PMID: 24293642.
143: Hung CS, Ho YL, Chang YY, Wu VC, Wu XM, Lee JK, Chueh SC, Lin YH, Changh
YS, Yang SY, Hu YH, Sui MJ, Chen MF, Wu KD. Twenty-four-hour urinary aldosterone
predicts inappropriate left ventricular mass index in patients with primary
aldosteronism. ScientificWorldJournal. 2013 Dec 29;2013:294594. doi:
10.1155/2013/294594. PMID: 24459427; PMCID: PMC3891226.
144: Wu VC, Wu CK, Chang YC, Young GH, Chen SC, Yang WS, Chen CY, Wang WJ, Lin
CY, Lin YH, Lin SL, Chueh SC, Wu KD; TAIPAI study group. Association of the
variations in the HSD3β gene with primary aldosteronism. J Hypertens. 2013
Jul;31(7):1396-405; discussion 1405. doi: 10.1097/HJH.0b013e328360ef3c. PMID:
24006038.
145: Wu CH, Yang YW, Hu YH, Tsai YC, Kuo KL, Lin YH, Hung SC, Wu VC, Wu KD;
Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group. Comparison of
24-h urinary aldosterone level and random urinary aldosterone-to-creatinine
ratio in the diagnosis of primary aldosteronism. PLoS One. 2013 Jun
28;8(6):e67417. doi: 10.1371/journal.pone.0067417. PMID: 23840695; PMCID:
PMC3696056.
146: Chao CT, Wu VC, Kuo CC, Lin YH, Chang CC, Chueh SJ, Wu KD, Pimenta E,
Stowasser M. Diagnosis and management of primary aldosteronism: an updated
review. Ann Med. 2013 Jun;45(4):375-83. doi: 10.3109/07853890.2013.785234. Epub
2013 May 23. PMID: 23701121.
147: Kao CC, Wu VC, Kuo CC, Lin YH, Hu YH, Tsai YC, Wu CH, Wu KD; TAIPAI study
group. Delayed diagnosis of primary aldosteronism in patients with autosomal
dominant polycystic kidney diseases. J Renin Angiotensin Aldosterone Syst. 2013
Jun;14(2):167-73. doi: 10.1177/1470320312452767. Epub 2012 Jul 12. PMID:
22791703.
148: Chang YY, Lee HH, Hung CS, Wu XM, Lee JK, Wang SM, Liao MT, Chen YH, Wu VC,
Lin YH, Wu KD; TAIPAI Study Group. WITHDRAWN: Association between the levels of
carboxy-terminal propeptide of type I procollagen and aldosterone in patients
with primary aldosteronism and essential hypertension. Clin Biochem. 2013 Jan
29:S0009-9120(13)00037-4. doi: 10.1016/j.clinbiochem.2013.01.010. Epub ahead of
print. PMID: 23376327.
149: Lee HH, Hung CS, Wu XM, Wu VC, Liu KL, Wang SM, Lin LC, Chen PC, Guo YL,
Chueh SC, Lin YH, Ho YL, Wu KD; Taipai Study Group. Myocardial ultrasound tissue
characterization of patients with primary aldosteronism. Ultrasound Med Biol.
2013 Jan;39(1):54-61. doi: 10.1016/j.ultrasmedbio.2012.08.023. PMID: 23200178.
150: Lin YH, Wu XM, Lee HH, Lee JK, Liu YC, Chang HW, Lin CY, Wu VC, Chueh SC,
Lin LC, Lo MT, Ho YL, Wu KD; TAIPAI Study Group. Adrenalectomy reverses
myocardial fibrosis in patients with primary aldosteronism. J Hypertens. 2012
Aug;30(8):1606-13. doi: 10.1097/HJH.0b013e3283550f93. PMID: 22688266.
151: Su MY, Wu VC, Yu HY, Lin YH, Kuo CC, Liu KL, Wang SM, Chueh SC, Lin LY, Wu
KD, Tseng WY. Contrast-enhanced MRI index of diffuse myocardial fibrosis is
increased in primary aldosteronism. J Magn Reson Imaging. 2012
Jun;35(6):1349-55. doi: 10.1002/jmri.23592. Epub 2012 Jan 26. PMID: 22282406.
152: Liao CH, Wu V, Chueh SJ, Sankari BR. Re: Outcome of surgery for primary
hyperaldosternonism. World J Surg. 2012 May;36(5):1209-10; author reply 1211-2.
doi: 10.1007/s00268-012-1540-1. PMID: 22407086.
153: Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C,
Deinum J, Fischer E, Gordon R, Kickuth R, Kline G, Lacroix A, Magill S, Miotto
D, Naruse M, Nishikawa T, Omura M, Pimenta E, Plouin PF, Quinkler M, Reincke M,
Rossi E, Rump LC, Satoh F, Schultze Kool L, Seccia TM, Stowasser M, Tanabe A,
Trerotola S, Vonend O, Widimsky J Jr, Wu KD, Wu VC, Pessina AC. The Adrenal Vein
Sampling International Study (AVIS) for identifying the major subtypes of
primary aldosteronism. J Clin Endocrinol Metab. 2012 May;97(5):1606-14. doi:
10.1210/jc.2011-2830. Epub 2012 Mar 7. PMID: 22399502.
154: Chang FC, Liu KL, Huang KH, Wu VC, Lin YH, Chen YM, Wu KD; TAIPAI Study
Group. Recurrence of primary aldosteronism after percutaneous ethanol injection.
J Formos Med Assoc. 2012 Mar;111(3):176-8. doi: 10.1016/j.jfma.2012.01.009. Epub
2012 Feb 9. PMID: 22423672.
155: Lin YH, Lin LY, Chen A, Wu XM, Lee JK, Su TC, Wu VC, Chueh SC, Lin WC, Lo
MT, Wang PC, Ho YL, Wu KD; TAIPAI Study Group. Adrenalectomy improves increased
carotid intima-media thickness and arterial stiffness in patients with
aldosterone producing adenoma. Atherosclerosis. 2012 Mar;221(1):154-9. doi:
10.1016/j.atherosclerosis.2011.12.003. Epub 2011 Dec 8. PMID: 22197109.
156: Liao CH, Wu V, Jeff Chueh S, Sankari BR. Outcome of Surgery for Primary
Hyperaldosteronism. World J Surg. 2012 Jan 28. doi: 10.1007/s00268-011-1370-6.
Epub ahead of print. PMID: 22286966.
157: Wu VC, Lo SC, Chen YL, Huang PH, Tsai CT, Liang CJ, Kuo CC, Kuo YS, Lee BC,
Wu EL, Lin YH, Sun YY, Lin SL, Chen JW, Lin SJ, Wu KD; TAIPAI Study Group.
Endothelial progenitor cells in primary aldosteronism: a biomarker of severity
for aldosterone vasculopathy and prognosis. J Clin Endocrinol Metab. 2011
Oct;96(10):3175-83. doi: 10.1210/jc.2011-1135. Epub 2011 Aug 3. PMID: 21816781.
158: Wu VC, Kuo CC, Wang SM, Liu KL, Huang KH, Lin YH, Chu TS, Chang HW, Lin CY,
Tsai CT, Lin LY, Chueh SC, Kao TW, Chen YM, Chiang WC, Tsai TJ, Ho YL, Lin SL,
Wang WJ, Wu KD; TAIPAI Study Group. Primary aldosteronism: changes in cystatin
C-based kidney filtration, proteinuria, and renal duplex indices with treatment.
J Hypertens. 2011 Sep;29(9):1778-86. doi: 10.1097/HJH.0b013e3283495cbb. PMID:
21738054.
159: Lin YH, Lee HH, Liu KL, Lee JK, Shih SR, Chueh SC, Lin WC, Lin LC, Lin LY,
Chung SD, Wu VC, Kuo CC, Ho YL, Chen MF, Wu KD; TAIPAI Study Group. Reversal of
myocardial fibrosis in patients with unilateral hyperaldosteronism receiving
adrenalectomy. Surgery. 2011 Sep;150(3):526-33. doi: 10.1016/j.surg.2011.02.006.
Epub 2011 Apr 22. PMID: 21514614.
160: Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, Yang WS, Tsai CW, Lai
CF, Lee TY, Lin WC, Wu MS, Lin YH, Chu TS, Lin CY, Chang HW, Wang WJ, Kao TW,
Chueh SC, Wu KD, Taipai Study Group. Verification and evaluation of
aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation
Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst. 2011
Sep;12(3):348-57. doi: 10.1177/1470320310391329. Epub 2011 Mar 10. PMID:
21393359.
161: Kuo CC, Wu VC, Tsai CW, Huang KH, Wang SM, Li BC, Chang CC, Lu CC, Yang WS,
Chao CT, Tsai IC, Lai CF, Lin WC, Wu MS, Lin YH, Lin CY, Chang HW, Wang WJ,
Chiang WC, Kao TW, Chueh SC, Chu TS, Tsai TJ, Wu KD; TAIPAI Study Group.
Combining body mass index and serum potassium to urine potassium clearance ratio
is an alternative method to predict primary aldosteronism. Clin Chim Acta. 2011
Aug 17;412(17-18):1637-42. doi: 10.1016/j.cca.2011.05.018. Epub 2011 May 19.
PMID: 21621528.
162: Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang
SM, Lin YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho
YL, Liu KL, Lin SL, Yen RF, Wu KD; TAIPAI Study Group. Kidney impairment in
primary aldosteronism. Clin Chim Acta. 2011 Jul 15;412(15-16):1319-25. doi:
10.1016/j.cca.2011.02.018. Epub 2011 Feb 21. PMID: 21345337.
163: Lin YH, Wang SM, Wu VC, Lee JK, Kuo CC, Yen RF, Liu KL, Huang KH, Chueh SC,
Wang WJ, Lin LY, Chien KL, Ho YL, Chen MF, Wu KD; TAIPAI study group. The
association of serum potassium level with left ventricular mass in patients with
primary aldosteronism. Eur J Clin Invest. 2011 Jul;41(7):743-50. doi:
10.1111/j.1365-2362.2010.02462.x. Epub 2011 Jan 21. PMID: 21250985.
164: Kuo CC, Wu VC, Tsai CW, Wu KD; Taiwan Primary Aldosteronism Investigation
(TAIPAI) Study Group). Relative kidney hyperfiltration in primary aldosteronism:
a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011 Jun;12(2):113-22.
doi: 10.1177/1470320310391331. Epub 2011 Mar 24. PMID: 21436207.
165: Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC, Chung SD, Liu KL, Chueh
SC, Lin LY, Ho YL, Chen MF, Wu KD; TAIPAI study group. Factors influencing left
ventricular mass regression in patients with primary aldosteronism post
adrenalectomy. J Renin Angiotensin Aldosterone Syst. 2011 Mar;12(1):48-53. doi:
10.1177/1470320310376424. Epub 2010 Aug 18. PMID: 20719880.
166: Chao CT, Chang FC, Wu VC, Chen JC; Taiwan Primary Aldosteronism
Investigation Study Group. Reninoma. Kidney Int. 2011 Jan;79(2):260. doi:
10.1038/ki.2010.445. PMID: 21191395.
167: Kuo CC, Hsu HL, Huang CY, Liu KL, Wu VC, Tsai CW, Wang WJ; Taiwan Primary
Aldosteronism Investigation Group (TAIPAI Group). A patient with concurrent
primary aldosteronism and Page kidney. Endocrine. 2010 Aug;38(1):6-10. doi:
10.1007/s12020-010-9352-2. Epub 2010 Jun 24. PMID: 20960095.
168: Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, Lin YH, Wang SM, Huang
KH, Fang CC, Ho YL, Liu KL, Chang CC, Chueh SC, Lin SL, Yen RF, Wu KD; TAIPAI
study group. Diagnosis of primary aldosteronism: comparison of post-captopril
active renin concentration and plasma renin activity. Clin Chim Acta. 2010 May
2;411(9-10):657-63. doi: 10.1016/j.cca.2010.01.027. Epub 2010 Feb 1. PMID:
20117105.
169: Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, Lin WC, Wu KD, Tzen KY,
Lu CC; TAIPAI Study Group. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for
primary aldosteronism patients with inconclusive adrenal venous sampling and CT
results. J Nucl Med. 2009 Oct;50(10):1631-7. doi: 10.2967/jnumed.109.064873.
Epub 2009 Sep 16. PMID: 19759122.
170: TAIPAI Study Group; Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho
YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh
BS, Wu KD. Association of kidney function with residual hypertension after
treatment of aldosterone-producing adenoma. Am J Kidney Dis. 2009
Oct;54(4):665-73. doi: 10.1053/j.ajkd.2009.06.014. Epub 2009 Jul 23. PMID:
19628318.
171: Kuo CC, Yang WS, Wu VC, Tsai CW, Wang WJ, Wu KD. Hypokalemic paralysis: the
interplay between primary aldosteronism and hyperthyroidism. Eur J Clin Invest.
2009 Aug;39(8):738-9. doi: 10.1111/j.1365-2362.2009.02159.x. Epub 2009 May 20.
PMID: 19476480.
172: Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, Lin WC, Ho YL, Huang JW, Chiang
CK, Yang SY, Chen YM, Wang SM, Huang KH, Hsieh BS, Wu KD; TAIPAI Study Group.
Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests.
Am J Hypertens. 2009 Aug;22(8):821-7. doi: 10.1038/ajh.2009.89. Epub 2009 May
14. PMID: 19444221.
173: Kuo CC, Wu VC, Tsai CW, Wang FF, Chueh SC, Wu KD. A rare cause of secondary
hypertension. NDT Plus. 2009 Apr;2(2):177-8. doi: 10.1093/ndtplus/sfn213. Epub
2009 Jan 28. PMID: 25949323; PMCID: PMC4421360.
174: Chang HW, Wu VC, Huang CY, Huang HY, Chen YM, Chu TS, Wu KD, Hsieh BS. D4
dopamine receptor enhances angiotensin II-stimulated aldosterone secretion
through PKC-epsilon and calcium signaling. Am J Physiol Endocrinol Metab. 2008
Mar;294(3):E622-9. doi: 10.1152/ajpendo.00657.2007. Epub 2008 Jan 2. PMID:
18171914.
175: Chang HW, Chu TS, Huang HY, Chueh SC, Wu VC, Chen YM, Hsieh BS, Wu KD.
Down-regulation of D2 dopamine receptor and increased protein kinase Cmu
phosphorylation in aldosterone-producing adenoma play roles in aldosterone
overproduction. J Clin Endocrinol Metab. 2007 May;92(5):1863-70. doi:
10.1210/jc.2006-2338. Epub 2007 Feb 13. PMID: 17299068.
更新日期:2023/11/17